Impact of Donor Hepatitis C Virus Infection Status on Death and Need for Liver Transplant in Hepatitis C Virus-Positive Kidney Transplant Recipients

被引:34
作者
Kucirka, Lauren M. [1 ]
Peters, Thomas G. [2 ]
Segev, Dorry L. [1 ,3 ]
机构
[1] Johns Hopkins Univ, Sch Med, Dept Surg, Baltimore, MD 21205 USA
[2] Univ Florida, Coll Med, Dept Surg, Jacksonville, FL USA
[3] Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA
关键词
Hepatitis C; kidney transplant; liver transplant; competing risks; RENAL-TRANSPLANTATION; SURVIVAL; DIALYSIS; RISK;
D O I
10.1053/j.ajkd.2012.03.015
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: Only 29% of deceased donor kidney recipients with hepatitis C virus (HCV) receive HCV-positive (HCV+) kidneys. These kidneys are discarded 2.5 times more often than their HCV-negative (HCV-) counterparts, possibly due to the sense that an HCV+ kidney may adversely affect recipient liver function. The goals of this study were to characterize liver disease in HCV+ kidney recipients and compare rates of liver-related outcomes by kidney donor HCV status. Study Design: Observational cohort study. Setting & Participants: 6,250 patients with HCV who had a kidney transplant in 1995-2008 as captured in the United Network for Organ Sharing (UNOS) database. Liver-related outcomes were assessed by cross-linking with the liver waitlist and transplant data sets. Predictor: HCV status of transplanted kidney. Outcomes: Joining the liver waitlist, receiving a liver transplant, death. Measurements: Time to event. Results: Only 63 (1%) of HCV+ kidney recipients eventually joined the liver waitlist during the 13-year study period. Those who received HCV+ kidneys had a 2.6-fold higher hazard of joining the liver list (P < 0.001); however, the absolute difference in rate of listing between recipients of HCV- and HCV+ kidneys was <2%. This is consistent with findings of only 2% lower patient survival at 3 years in HCV+ patients receiving HCV+ versus HCV- kidneys. Limitations: We lacked data for HCV viral load and genotype of both HCV+ recipients and transplanted HCV+ kidneys. Conclusions: Because transplant with an HCV+ kidney may reduce waiting-time by more than a year for an HCV+ patient and there is a high risk of kidney waitlist mortality, a 2% increased rate of adverse liver outcomes and 2% increased rate of death at 3 years should not universally preclude the use of HCV+ kidneys when the intended recipient is also HCV+. Am J Kidney Dis. 60(1):112-120. (C) 2012 by the National Kidney Foundation, Inc.
引用
收藏
页码:112 / 120
页数:9
相关论文
共 14 条
[1]   The impact of transplantation with deceased donor hepatitis C-positive kidneys on survival in wait-listed long-term dialysis patients [J].
Abbott, KC ;
Lentine, KL ;
Bucci, JR ;
Agodoa, LY ;
Peters, TG ;
Schnitzler, MA .
AMERICAN JOURNAL OF TRANSPLANTATION, 2004, 4 (12) :2032-2037
[2]  
Batty DS, 2001, AM J TRANSPLANT, V1, P179, DOI 10.1034/j.1600-6143.2001.10213.x
[3]   Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list [J].
Bloom, RD ;
Sayer, G ;
Fa, K ;
Constantinescu, S ;
Abt, P ;
Reddy, KR .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (01) :139-144
[4]  
BUCCI JR, 2004, CLIN TRANSPL, V18, P51
[5]   Impact of hepatitis C virus infection and other comorbidities on survival in patients on dialysis [J].
Butt, A. A. ;
Skanderson, M. ;
McGinnis, K. A. ;
Ahuja, T. ;
Bryce, C. L. ;
Barnato, A. E. ;
Chang, C.-C. H. .
JOURNAL OF VIRAL HEPATITIS, 2007, 14 (10) :688-696
[6]   Racial disparities in access to renal transplantation - Clinically appropriate or due to underuse or overuse? [J].
Epstein, AM ;
Ayanian, JZ ;
Keogh, JH ;
Noonan, SJ ;
Armistead, N ;
Cleary, PD ;
Weissman, JS ;
David-Kasdan, JA ;
Carlson, D ;
Fuller, J ;
Marsh, D ;
Conti, RM .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (21) :1537-U8
[7]   Current status of renal transplantation from HCV-positive donors [J].
Fabrizi, Fabrizio ;
Messa, Piergiorgio ;
Martin, Paul .
INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (05) :251-261
[8]   A proportional hazards model for the subdistribution of a competing risk [J].
Fine, JP ;
Gray, RJ .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1999, 94 (446) :496-509
[9]   Hepatitis C virus and death risk in hemodialysis patients [J].
Kalantar-Zadeh, Kamyar ;
Kilpatrick, Ryan D. ;
McAllister, Charles J. ;
Miller, Loren G. ;
Daar, Eric S. ;
Gjertson, David W. ;
Kopple, Joel D. ;
Greerdand, Sander .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2007, 18 (05) :1584-1593
[10]   Underutilization of Hepatitis C-Positive Kidneys for Hepatitis C-Positive Recipients [J].
Kucirka, L. M. ;
Singer, A. L. ;
Ros, R. L. ;
Montgomery, R. A. ;
Dagher, N. N. ;
Segev, D. L. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) :1238-1246